Effects of Peridialytic Oral Supplements on Nutritional Status and Quality of Life in Chronic Hemodialysis Patients

Meri Kay Scott, Niyati A. Shah, A. Mary Vilay, Joseph Thomas, Michael Kraus, Bruce A. Mueller

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective: Our objective was to determine the effects of peridialytic oral supplements on nutritional markers and quality of life (QOL) in patients receiving maintenance hemodialysis. Design: This trial was open, prospective, nonrandomized, and comparative. Setting: This study was performed at an outpatient hemodialysis unit in a teaching hospital. Patients: This study included 88 adults with chronic kidney disease at stage 5. Intervention: This study involved directly observed nutrition therapy with ≥1 can of enteral nutrition (Nepro) with each hemodialysis session thrice weekly for 3 months, or standard care. Main Outcome Measure: Changes in biochemical markers of nutritional status and QOL, as measured by the Kidney Disease Quality of Life-Short Form, were determined. Results: Peridialytic oral nutrition resulted in a significant difference between the nutrition and comparison groups in serum albumin change over time (P = .03; repeated-measures analysis of variance with covariates). Mean (±SD) serum albumin concentration did not differ between baseline and month 3 in the nutrition group (3.68 ± 0.33 g/dL vs. 3.75 ± 0.40 g/dL; P = .12), but in the comparison group, serum albumin levels declined significantly (3.93 ± 0.34 g/dL at baseline versus 3.81 ± 0.37 g/dL at month 3; P = .04). The "role-physical" domain score of the Kidney Disease Quality of Life-Short Form significantly changed over time in the nutrition group versus the comparison group (P = .02; repeated-measures analysis of variance with covariates). Nepro was well-tolerated, and greater than 80% of the prescribed therapy was consumed. Conclusion: Oral nutrition, as part of structured, directly observed peridialytic therapy in chronic hemodialysis patients, was well-accepted, and resulted in the maintenance of serum albumin levels and QOL with respect to impact of physical health on daily activities. These findings need to be confirmed in a randomized, controlled trial.

Original languageEnglish
Pages (from-to)145-152
Number of pages8
JournalJournal of Renal Nutrition
Volume19
Issue number2
DOIs
StatePublished - Mar 2009

Fingerprint

Nutritive Value
Nutritional Status
Renal Dialysis
Serum Albumin
Quality of Life
Directly Observed Therapy
Kidney Diseases
Analysis of Variance
Maintenance
Nutrition Therapy
Enteral Nutrition
Chronic Renal Insufficiency
Teaching Hospitals
Outpatients
Randomized Controlled Trials
Biomarkers
Outcome Assessment (Health Care)
Health

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Nephrology

Cite this

Effects of Peridialytic Oral Supplements on Nutritional Status and Quality of Life in Chronic Hemodialysis Patients. / Scott, Meri Kay; Shah, Niyati A.; Vilay, A. Mary; Thomas, Joseph; Kraus, Michael; Mueller, Bruce A.

In: Journal of Renal Nutrition, Vol. 19, No. 2, 03.2009, p. 145-152.

Research output: Contribution to journalArticle

Scott, Meri Kay ; Shah, Niyati A. ; Vilay, A. Mary ; Thomas, Joseph ; Kraus, Michael ; Mueller, Bruce A. / Effects of Peridialytic Oral Supplements on Nutritional Status and Quality of Life in Chronic Hemodialysis Patients. In: Journal of Renal Nutrition. 2009 ; Vol. 19, No. 2. pp. 145-152.
@article{573bca08892144de8dc920a169ac763f,
title = "Effects of Peridialytic Oral Supplements on Nutritional Status and Quality of Life in Chronic Hemodialysis Patients",
abstract = "Objective: Our objective was to determine the effects of peridialytic oral supplements on nutritional markers and quality of life (QOL) in patients receiving maintenance hemodialysis. Design: This trial was open, prospective, nonrandomized, and comparative. Setting: This study was performed at an outpatient hemodialysis unit in a teaching hospital. Patients: This study included 88 adults with chronic kidney disease at stage 5. Intervention: This study involved directly observed nutrition therapy with ≥1 can of enteral nutrition (Nepro) with each hemodialysis session thrice weekly for 3 months, or standard care. Main Outcome Measure: Changes in biochemical markers of nutritional status and QOL, as measured by the Kidney Disease Quality of Life-Short Form, were determined. Results: Peridialytic oral nutrition resulted in a significant difference between the nutrition and comparison groups in serum albumin change over time (P = .03; repeated-measures analysis of variance with covariates). Mean (±SD) serum albumin concentration did not differ between baseline and month 3 in the nutrition group (3.68 ± 0.33 g/dL vs. 3.75 ± 0.40 g/dL; P = .12), but in the comparison group, serum albumin levels declined significantly (3.93 ± 0.34 g/dL at baseline versus 3.81 ± 0.37 g/dL at month 3; P = .04). The {"}role-physical{"} domain score of the Kidney Disease Quality of Life-Short Form significantly changed over time in the nutrition group versus the comparison group (P = .02; repeated-measures analysis of variance with covariates). Nepro was well-tolerated, and greater than 80{\%} of the prescribed therapy was consumed. Conclusion: Oral nutrition, as part of structured, directly observed peridialytic therapy in chronic hemodialysis patients, was well-accepted, and resulted in the maintenance of serum albumin levels and QOL with respect to impact of physical health on daily activities. These findings need to be confirmed in a randomized, controlled trial.",
author = "Scott, {Meri Kay} and Shah, {Niyati A.} and Vilay, {A. Mary} and Joseph Thomas and Michael Kraus and Mueller, {Bruce A.}",
year = "2009",
month = "3",
doi = "10.1053/j.jrn.2008.08.004",
language = "English",
volume = "19",
pages = "145--152",
journal = "Journal of Renal Nutrition",
issn = "1051-2276",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Effects of Peridialytic Oral Supplements on Nutritional Status and Quality of Life in Chronic Hemodialysis Patients

AU - Scott, Meri Kay

AU - Shah, Niyati A.

AU - Vilay, A. Mary

AU - Thomas, Joseph

AU - Kraus, Michael

AU - Mueller, Bruce A.

PY - 2009/3

Y1 - 2009/3

N2 - Objective: Our objective was to determine the effects of peridialytic oral supplements on nutritional markers and quality of life (QOL) in patients receiving maintenance hemodialysis. Design: This trial was open, prospective, nonrandomized, and comparative. Setting: This study was performed at an outpatient hemodialysis unit in a teaching hospital. Patients: This study included 88 adults with chronic kidney disease at stage 5. Intervention: This study involved directly observed nutrition therapy with ≥1 can of enteral nutrition (Nepro) with each hemodialysis session thrice weekly for 3 months, or standard care. Main Outcome Measure: Changes in biochemical markers of nutritional status and QOL, as measured by the Kidney Disease Quality of Life-Short Form, were determined. Results: Peridialytic oral nutrition resulted in a significant difference between the nutrition and comparison groups in serum albumin change over time (P = .03; repeated-measures analysis of variance with covariates). Mean (±SD) serum albumin concentration did not differ between baseline and month 3 in the nutrition group (3.68 ± 0.33 g/dL vs. 3.75 ± 0.40 g/dL; P = .12), but in the comparison group, serum albumin levels declined significantly (3.93 ± 0.34 g/dL at baseline versus 3.81 ± 0.37 g/dL at month 3; P = .04). The "role-physical" domain score of the Kidney Disease Quality of Life-Short Form significantly changed over time in the nutrition group versus the comparison group (P = .02; repeated-measures analysis of variance with covariates). Nepro was well-tolerated, and greater than 80% of the prescribed therapy was consumed. Conclusion: Oral nutrition, as part of structured, directly observed peridialytic therapy in chronic hemodialysis patients, was well-accepted, and resulted in the maintenance of serum albumin levels and QOL with respect to impact of physical health on daily activities. These findings need to be confirmed in a randomized, controlled trial.

AB - Objective: Our objective was to determine the effects of peridialytic oral supplements on nutritional markers and quality of life (QOL) in patients receiving maintenance hemodialysis. Design: This trial was open, prospective, nonrandomized, and comparative. Setting: This study was performed at an outpatient hemodialysis unit in a teaching hospital. Patients: This study included 88 adults with chronic kidney disease at stage 5. Intervention: This study involved directly observed nutrition therapy with ≥1 can of enteral nutrition (Nepro) with each hemodialysis session thrice weekly for 3 months, or standard care. Main Outcome Measure: Changes in biochemical markers of nutritional status and QOL, as measured by the Kidney Disease Quality of Life-Short Form, were determined. Results: Peridialytic oral nutrition resulted in a significant difference between the nutrition and comparison groups in serum albumin change over time (P = .03; repeated-measures analysis of variance with covariates). Mean (±SD) serum albumin concentration did not differ between baseline and month 3 in the nutrition group (3.68 ± 0.33 g/dL vs. 3.75 ± 0.40 g/dL; P = .12), but in the comparison group, serum albumin levels declined significantly (3.93 ± 0.34 g/dL at baseline versus 3.81 ± 0.37 g/dL at month 3; P = .04). The "role-physical" domain score of the Kidney Disease Quality of Life-Short Form significantly changed over time in the nutrition group versus the comparison group (P = .02; repeated-measures analysis of variance with covariates). Nepro was well-tolerated, and greater than 80% of the prescribed therapy was consumed. Conclusion: Oral nutrition, as part of structured, directly observed peridialytic therapy in chronic hemodialysis patients, was well-accepted, and resulted in the maintenance of serum albumin levels and QOL with respect to impact of physical health on daily activities. These findings need to be confirmed in a randomized, controlled trial.

UR - http://www.scopus.com/inward/record.url?scp=60649112308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60649112308&partnerID=8YFLogxK

U2 - 10.1053/j.jrn.2008.08.004

DO - 10.1053/j.jrn.2008.08.004

M3 - Article

VL - 19

SP - 145

EP - 152

JO - Journal of Renal Nutrition

JF - Journal of Renal Nutrition

SN - 1051-2276

IS - 2

ER -